Filters: keyword is Drug Delivery Systems [Clear All Filters]
- 2007
Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis,
Annu Rev Pharmacol Toxicol, vol. 47, pp. 357-400.
- 2005
Targeting liposomes with protein drugs to the blood-brain barrier in vitro,
Eur J Pharm Sci, vol. 25, no. 2-3, pp. 299-305.
- 2004
Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro,
J Drug Target, vol. 12, no. 3, pp. 145-50.
Coupling of metal containing homing devices to liposomes via a maleimide linker: use of TCEP to stabilize thiol-groups without scavenging metals,
J Drug Target, vol. 12, no. 9-10, pp. 569-73.
- 2003
Iontophoretic R-apomorphine delivery in combination with surfactant pretreatment: in vitro validation studies,
Int J Pharm, vol. 266, no. 1-2, pp. 61-8.
Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro,
Pharm Res, vol. 20, no. 4, pp. 653-9.
- 2002
Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain,
Clin Pharmacokinet, vol. 41, no. 10, pp. 691-703.
- 1997
Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "wooden shoe' paradigm,
Clin Pharmacokinet, vol. 32, no. 4, pp. 259-67.
